The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kolbanov K.I.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ

Trakhtenberg A.Kh.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ

Pikin O.V.

FGBU "MNIOI im. P.A. Gertsena" Minzdrava Rossii

Glushko V.A.

P.A. Gertsen Moscow Research Cancer Institute, Russian Ministry of Health

Bagrov V.A.

P.A. Hertzen Moscow Research Institute of Oncology, Russian Federation, Moscow

Surgical treatment in patients with Stage I peripheral non-small cell lung cancer: Results, prognosis, prospects

Authors:

Kolbanov K.I., Trakhtenberg A.Kh., Pikin O.V., Glushko V.A., Bagrov V.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2016;5(5): 4‑10

DOI: 10.17116/onkolog2016554-10

Read: 3736 times

Download PDF (RU)
Contact the author
Table of contents

SURGICAL TREATMENT IN PATIENTS WITH STAGE I PERIPHERAL NON-SMALL CELL LUNG CANCER: RESULTS, PROGNOSIS, PROSPECTS
SURGICAL TREATMENT IN PATIENTS WITH STAGE I PERIPHERAL NON-SMALL CELL LUNG CANCER: RESULTS, PROGNOSIS, PROSPECTS

To cite this article:

Kolbanov KI, Trakhtenberg AKh, Pikin OV, Glushko VA, Bagrov VA. Surgical treatment in patients with Stage I peripheral non-small cell lung cancer: Results, prognosis, prospects. P.A. Herzen Journal of Oncology. 2016;5(5):4‑10. (In Russ.)
https://doi.org/10.17116/onkolog2016554-10

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Surgical mana­gement of patients with local recu­rrence of renal cancer. Prognostic factors of survival. P.A. Herzen Journal of Onco­logy. 2025;(3):20-24
Effi­cacy of chemoimmunotargeted therapy in patients with adva­nced non-small cell lung cancer in real clinical practice. P.A. Herzen Journal of Onco­logy. 2025;(3):63-70
The role of perioperative reha­bilitation of patients in surgical treatment of pelvic and lower extremity bone tumors with endo­prosthesis. P.A. Herzen Journal of Onco­logy. 2025;(4):22-28
The effe­ctiveness of combined chemotherapy and immu­notherapy, and the search for personalized approaches to treating adva­nced non-small cell lung cancer. P.A. Herzen Journal of Onco­logy. 2025;(4):37-45
Peri­neal endo­metriosis after deli­very: causes of deve­lopment, treatment, prevention. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):79-83
Surgical significance of various types of inte­rnal caro­tid artery tortuosity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):392-398
Pregnancy in a patient with fami­lial adenomatous poly­posis of the colon. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):94-97
Targeted bone rege­neration in the treatment of patients with chro­nic gene­ralized periodontitis. Stomatology. 2025;(4):33-36
A clinical case of surgical treatment of a large odontogenic kera­tocyst. Stomatology. 2025;(4):93-97
Morphological examination of surgical mate­rial of primary lung cancer after neoadjuvant therapy: reco­mmendations and lite­rature review. Russian Journal of Archive of Pathology. 2025;(4):40-46
Abstract:

Surgical treatment, the minimal volume of which is lobectomy with mediastinal lymphadenectomy, is considered the method of choice in functionally operable patients with non-small cell lung cancer (NSCLC). Objective: to retrospectively assesse the results of surgical treatment in patients with peripheral NSCLC (T1—2aN0M0) in view of the volume of surgery and a number of other clinical and morphological factors. Subjects and methods. The analysis included 363 patients with a peripheral NSCLC of less than 4 cm without lymph node metastasis, who had undergone lobectomy (91.2%), segmentectomy (3.6%), or nonanatomic lung resection (5.2%). The patients’ mean age was 59.8 years; there was a preponderance of males (80.2%). The tumor was more often localized in the right lung (54.0%) and upper lobes (66.1%). Stages IA (pT1а—bN0M0) and IB (рT2aN0M0) were diagnosed in 188 and 175 patients, respectively. There was adenocarcinoma in 47.4% of the patients, squamous cell carcinoma in 39.2%, large cell carcinoma in 5.8%, adenosquamous carcinoma in 6.0%, and mucoepidermoid carcinoma in 1.6%. Results. Postoperative complications were diagnosed in 10.2% of the patients; the mortality rates were 1.4%. The 5-year overall survival rates for the patients were as high as 71%; those for Т1a—b and Т2а were 76.1 and 67.1%, respectively (p>0.05). The highest rates were seen for squamous cell carcinoma (77.5%) and adenocarcinoma (68.0%; p>0.05); lower rates were observed for large cell carcinoma (50.4%; p=0.03). A poor prognosis was established in patients after nonanatomic lung resection (43.8%; p<0.001) compared to those following transthoracic lobectomy (72.4%) and segmentectomy (81.5%; p>0.05). The 5-year overall survival rate after video-assisted thoracoscopic lobectomy was comparable with that following thoracotomies. A multivariate analysis confirmed that the morphological type of NSCLC and the volume of surgery had a negative impact on the long-term results of the latter. Conclusion. The poor clinical and morphological prognostic factors for surgical treatment in patients with NSCLC (Т1—2аN0M0) should include large cell lung carcinoma and an operation as nonanatomic sublobar resection. Segmentectomy may be considered the standard treatment volume in only patients with NSCLC (T1aN0M0).

Keywords:

non-small cell lung cancer
surgical treatment
prognostic factors
segmentectomy

Authors:

Kolbanov K.I.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ

Trakhtenberg A.Kh.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ

Pikin O.V.

FGBU "MNIOI im. P.A. Gertsena" Minzdrava Rossii

Glushko V.A.

P.A. Gertsen Moscow Research Cancer Institute, Russian Ministry of Health

Bagrov V.A.

P.A. Hertzen Moscow Research Institute of Oncology, Russian Federation, Moscow

Close metadata

References:

  1. Kaprin A, Starinskii V, Petrova G, eds. Malignancies in Russia in 2013 (morbidity and mortality) [Zlokachestvennye novoobrazovaniya v Rossii v 2013 godu (zabolevaemost' i smertnost')]. Moscow: MNIOI im. P.A. Gertsena — filial FGBU «FMITs im. P.A. Gertsena» Minzdrava Rossii; 2015. (In Russ.)
  2. Vansteenkiste J, Crino L, Dooms C, Douillard J, Faivre-Finn C, Lim E et al. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 2014;25(8):1462-1474. doi: 10.1093/annonc/mdu089
  3. McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg. 2006;81(2):421-425;discussion 425-426. doi: 10.1016/j.athoracsur.2005.07.078
  4. Sigal E, Khamidulin R, Burmistrov M. The results of videothoracoscopy in diagnostics and treatment. In: Proceedings of the I international conference on thoracic surgery [Materialy I mezhdunarodnoi konferentsii po torakal'noi khirurgii]. Мoscow; 2008:312p. (In Russ.)
  5. Stephens N, Rice D, Correa A, Hoffstetter W, Mehran R, Roth J et al. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases. Eur J Cardiothorac Surg. 2014;46(4):607-613. doi: 10.1093/ejcts/ezu036
  6. Pikin O. Thoracoscopic lobectomy in peripheral non-small cell lung cancer. In: Sigal E, Zhestkov K, Burmistrov M, Pikin O. Thoracoscopic surgery [Torakoskopicheskaya khirurgiya]. Fedorov I, ed. Moscow: Izdatel'stvo «Avtorskaya kniga»; 2012:160-174. (In Russ.)
  7. Goya T, Asamura H, Yoshimura H, Kato H, Shimokata K, Tsuchiya R et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer. 2005;50(2):227-234. doi: 10.1016/j.lungcan.2005.05.021
  8. Koike T, Tsuchiya R, Goya T, Sohara Y, Miyaoka E. Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan. J Thorac Oncol. 2007;2(5):408-413. doi: 10.1097/01.JTO.0000268674.02744.f9
  9. Cerfolio R, Bryant A. Survival of patients with true pathologic stage I non-small cell lung cancer. Ann Thorac Surg. 2009;88(3):917-923. doi: 10.1016/j.athoracsur.2009.05.040
  10. Saito Y, Kawai Y, Takahashi N, Ikeya T, Murai K, Kawabata Y, Hoshi E. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2011;92(5):1812-1817. doi: 10.1016/j.athoracsur.2011.06.055
  11. Carr SR, Schuchert MJ, Pennathur A, Wilson DO, Siegfried JM et al. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system. J Thorac Cardiovasc Surg. 2012;143(2):390-397. doi: 10.1016/j.jtcvs.2011.10.023
  12. Yamashita Y, Mukaida H, Harada H, Tsubokawa N. Post-thoracotomy pain and long-term survival associated with video-assisted thoracic surgery lobectomy methods for clinical T1N0 lungcancer: a patient-oriented, prospective cohort study. Eur J Cardiothorac Surg. 2013;44(1):e71-e76. doi: 10.1093/ejcts/ezt107
  13. Yano M, Yoshida J, Koike T, Kameyama K, Shimamoto A, Nishio W et al. Survival of 1737 lobectomy-tolerable patients who underwent limited resection for cStage IA non-small-cell lung cancer. Eur J Cardiothorac Surg. 2015;47(1):135-142. doi: 10.1093/ejcts/ezu138
  14. Hung JJ, Jeng WJ, Hsu WH, Lin SF, Hsieh CC, Huang BS et al. Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm. Eur Respir J. 2010;36(6):1355-1361. doi: 10.1183/09031936.00014109
  15. Lin ZZ, Shau WY, Shao YY, Yang YY, Kuo RN, Yang JC, Lai MS. Survival following surgery with or without adjuvant chemotherapy for stage I—IIIA non-small cell lung cancer: An East Asian Population-Based Study. Oncologist. 2012;17(10):1294-1302. doi: 10.1634/theoncologist.2012-0082
  16. Puri V, Garg N, Engelhardt E, Kreisel D, Crabtree T, Meyers B et al. Tumor location is not an independent prognostic factor in early stage non-small cell lung cancer. Ann Thorac Surg. 2010;89(4):1053-1059. doi: 10.1016/j.athoracsur.2010.01.020
  17. Luzzi L, Marulli G, De Palma A, Meniconi F, Stocca F, Loizzi M et al. Prognostic factors and clinical outcome of patients with peripheral N0 adenocarcinoma. Interact Cardiovasc Thorac Surg. 2013;17(Suppl.2):S89. doi: 10.1093/icvts/ivt372.83
  18. Takei H, Goya T, Tsukada H. Video-assisted thoracic surgery (VATS) for lung cancer. Gan To Kagaku Ryoho. 2005;32(9):1235-1239.
  19. Swanson SJ, Herndon JE 2nd, D'Amico ThA, Demmy TL, McKenna RJ Jr, Green MR, Sugarbaker DJ. Video-assisted thoracic surgery lobectomy: report of CALGB 39802-a prospective, multi-institution feasibility study. J Clin Oncol. 2007;25(31):4993-4997. doi: 10.1200/JCO.2007.12.6649
  20. Hansen HJ, Petersen RH, Christensen M. Video-assisted thoracoscopic surgery (VATS) lobectomy using a standardized anterior approach. Surg Endosc. 2011;25(4):1263-1269. doi: 10.1007/s00464-010-1355-9
  21. Weissberg D, Straehley CJ, Scully NM, Margulies DR. Less than lobar resections for bronchogenic carcinoma. Scand J Thorac Cardiovasc Surg. 1993;27(3-4):121-126. doi: 10.3109/14017439309099098
  22. Pastorino U, Valente M, Bedini V, Infante M, Tavecchio L, Gherardini G et al. Limited resection for stage I lung cancer. Lung Cancer. 1991;7:85. doi: 10.1016/0169-5002(91)91660-4
  23. Kaneda M, Watanabe F, Tarukawa T, Tokui T, Sakai T. Limited operation for lung cancer in combination with postoperative radiation therapy. Ann Thorac Cardiovasc Surg. 2007;13(1):15-20.
  24. Trodella L, Granone P, Valente S, Valentini V, Balducci M, Mantini G et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol. 2002;62(1):11-19. doi: 10.1016/s0167-8140(01)00478-9
  25. Kharchenko V, Galil-Ogly G, Teiblyum M, Kuz'min I, Il'in V, Lebedev V, Khmelevskii E, Pan'shin A, Goloborod'ko L, Gurevich L. Radiation pneumonitis and pulmonary fibrosis after organ combined treatment of patients with stage I lung cancer. Rossiiskii onkologicheskii zhurnal. 1998;4:43-47. (In Russ.)
  26. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg. 2005;129(1):87-93. doi: 10.1093/ejcts/ezu429
  27. Okumura M, Goto M, Ideguchi K, Tamura M, Sasaki H, Tanaka H et al. Factors associated with outcome of segmentectomy for non-small cell lung cancer: long-term follow-up study at a single institution in Japan. Lung Cancer. 2007;58(2):231-237. doi: 10.1016/j.lungcan.2007.06.014
  28. Sienel W, Stremmel C, Kirschbaum A, Hinterberger L, Stoelben E, Hasse J et al. Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins — implications for patient selection for segmentectomy. Eur J Cardiothorac Surg. 2007;31(3):522-528. doi: 10.1016/j.ejcts.2006.12.018
  29. Ogawa H, Uchino K, Tanaka Y, Shimizu N, Okuda Y, Tane K et al. Outcomes of segmentectomy for cT1bN0M0 lung adenocarcinoma and squamous cell carcinoma: a possible association with pathological invasion. Eur J Cardiothorac Surg. 2015;48(1):77-82. doi: 10.1093/ejcts/ezu429
  30. Krbek T, Kopeika U, Kolb J, Traykov P, Kambartel K, Voshaar T. Locoregional recurrence after pulmonary segmentectomy of non-small cell lung cancer. Eur Respir J. 2013;42:P458. Available at: http://erj.ersjournals.com/content/42/Suppl_57/P458.abstract
  31. Landreneau RJ, Normolle DP, Christie NA, Awais O, Wizorek JJ, Abbas G et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small cell lung cancer: a propensity-matched analysis. J Clin Oncol. 2014;32(23):2449-2455.
  32. Kilic A, Schuchert MJ, Pettiford BL, Pennathur A, Landreneau JR et al. Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. Ann Thorac Surg. 2009;87(6):1662-6;discussion 1667-1668. doi: 10.1016/j.athoracsur.2009.02.097
  33. Schuchert MJ, Awais O, Abbas G, Horne ZD, Nason KS, Pennathur A et al. Influence of age and IB status after resection of node-negative non-small cell lung cancer. Ann Thorac Surg. 2012;93(3):929-935;discussion 935-936. doi: 10.1016/j.athoracsur.2011.09.047
  34. Trakhtenberg A, Chissov V. Lung cancer [Rak legkogo]. Moscow: GEOTAR-Media; 2009. (In Russ.)
  35. Popov M, Blinov D. Anatomic segmentectomy in peripheral stage I lung cancer as an alternative to lobectomy. Voprosy onkologii. 2013;59(Suppl.3):398. (In Russ.)
  36. Sienel W, Dango S, Kirschbaum A, Cucuruz B, Horth W, Stremmel C et al. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg. 2008;33(4):728-734. doi: 10.1016/j.ejcts.2007.12.048
  37. Mediratta N, Shackcloth M, Page R, Woolley S, Asante-Siaw J, Poullis M. Should males ever undergo wedge resection for stage I non-small-cell lung cancer? A propensity analysis. Eur J Cardiothorac Surg. 2014;46(2):267-273. doi: 10.1093/ejcts/ezt603
  38. Schuchert MJ, Pettiford BL, d’Amato TA, Keeley S, Close J et al. Anatomic segmentectomy for stage I non-small cell lung cancer. Ann Thorac Surg. 2007;84(3):926-932;discussion 932-933. doi: 10.1016/j.athoracsur.2007.05.007
  39. Zhong C, Fang W, Mao T, Yao F, Chen W, Hu D. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy for small-sized stage IA lung cancer. Ann Thorac Surg. 2012;94(2):362-367. doi: 10.1016/j.athoracsur.2012.04.047
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.